More than 55 million people live with Alzheimer’s — but global access to treatment is deeply unequal.
Despite limited resources, Cuba’s public biotech sector developed NeuroEPO, a treatment that has shown promising results in slowing the disease’s progression. But access, visibility, and support are blocked by U.S. sanctions and outdated Cold War policies.
Scientist Teresita Rodríguez and her team — made up largely of women — are leading a story of science, care, and resistance.
The film’s engagement campaign is about recognizing that story, sharing it, and building bridges that can shift how the world treats aging, illness, and its people.
No comments:
Post a Comment